» Articles » PMID: 36145595

Extracellular Vesicles: A New Frontier for Cardiac Repair

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Sep 23
PMID 36145595
Authors
Affiliations
Soon will be listed here.
Abstract

The ability of extracellular vesicles (EVs) to regulate a broad range of cellular processes has recently been used to treat diseases. Growing evidence indicates that EVs play a cardioprotective role in heart disease by activating beneficial signaling pathways. Multiple functional components of EVs and intracellular molecular mechanisms are involved in the process. To overcome the shortcomings of native EVs such as their heterogeneity and limited tropism, a series of engineering approaches has been developed to improve the therapeutic efficiency of EVs. In this review, we present an overview of the research and future directions for EVs-based cardiac therapies with an emphasis on EVs-mediated delivery of therapeutic agents. The advantages and limitations of various modification strategies are discussed, and possible opportunities for improvement are proposed. An in-depth understanding of the endogenous properties of EVs and EVs engineering strategies could lead to a promising cell-free therapy for cardiac repair.

Citing Articles

Assessing the Potential Benefits of Stem Cell Therapy in Cardiac Regeneration for Patients With Ischemic Heart Disease.

Ali S, Mahmood Z, Mubarak Z, Asad M, Sarfraz Chaudhri M, Bilal L Cureus. 2025; 17(1):e76770.

PMID: 39897258 PMC: 11786102. DOI: 10.7759/cureus.76770.


NMF typing and machine learning algorithm-based exploration of preeclampsia-related mechanisms on ferroptosis signature genes.

Liu X, Zhang D, Qiu H Cell Biol Toxicol. 2024; 41(1):14.

PMID: 39707003 PMC: 11662041. DOI: 10.1007/s10565-024-09963-5.


Mesenchymal stem cells and their extracellular vesicles in bone and joint diseases: targeting the NLRP3 inflammasome.

Xu S, Zhang Y, Zheng Z, Sun J, Wei Y, Ding G Hum Cell. 2024; 37(5):1276-1289.

PMID: 38985391 DOI: 10.1007/s13577-024-01101-x.


Intramyocardial Injection of Hypoxia-Conditioned Extracellular Vesicles Modulates Response to Oxidative Stress in the Chronically Ischemic Myocardium.

Harris D, Sabe S, Broadwin M, Xu C, Stone C, Kanuparthy M Bioengineering (Basel). 2024; 11(2).

PMID: 38391611 PMC: 10886197. DOI: 10.3390/bioengineering11020125.


Immunometabolism, extracellular vesicles and cardiac injury.

Omoto A, do Carmo J, da Silva A, Hall J, Mouton A Front Endocrinol (Lausanne). 2024; 14:1331284.

PMID: 38260141 PMC: 10800986. DOI: 10.3389/fendo.2023.1331284.


References
1.
Meldolesi J . Exosomes and Ectosomes in Intercellular Communication. Curr Biol. 2018; 28(8):R435-R444. DOI: 10.1016/j.cub.2018.01.059. View

2.
Chang E, Nayak L, Jain M . Krüppel-like factors in endothelial cell biology. Curr Opin Hematol. 2017; 24(3):224-229. DOI: 10.1097/MOH.0000000000000337. View

3.
Zhang Y, Cai Z, Shen Y, Lu Q, Gao W, Zhong X . Hydrogel-load exosomes derived from dendritic cells improve cardiac function via Treg cells and the polarization of macrophages following myocardial infarction. J Nanobiotechnology. 2021; 19(1):271. PMC: 8424987. DOI: 10.1186/s12951-021-01016-x. View

4.
Martinez-Greene J, Hernandez-Ortega K, Quiroz-Baez R, Resendis-Antonio O, Pichardo-Casas I, Sinclair D . Quantitative proteomic analysis of extracellular vesicle subgroups isolated by an optimized method combining polymer-based precipitation and size exclusion chromatography. J Extracell Vesicles. 2021; 10(6):e12087. PMC: 8077108. DOI: 10.1002/jev2.12087. View

5.
Xiao J, Pan Y, Li X, Yang X, Feng Y, Tan H . Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. Cell Death Dis. 2016; 7(6):e2277. PMC: 5143405. DOI: 10.1038/cddis.2016.181. View